← Eichor
Condition: Haploidentical Hematopoietic Stem Cell Transplantation Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Haploidentical Hematopoietic Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Ce
Phase 1 · 21 location(s) · TScan Therapeutics, Inc. · NCT05473910MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NA · 1 location(s) · Medical College of Wisconsin · NCT05794880Haplo-Cord HSCT for AML/MDS
NA · 4 location(s) · Fujian Medical University Union Hospital · NCT07588360TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic D
Phase 2 · 1 location(s) · Johns Hopkins All Children's Hospital · NCT04414046Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyc
Phase 1 · 2 location(s) · University of Kansas Medical Center · NCT03533816A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT07586735BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
Phase 2 · 1 location(s) · BioPhoenix Co., Ltd. · NCT07246031IS-free Treg HaploHCT
Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT04678401CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT
Phase 1/Phase 2 · 2 location(s) · University Hospital Tuebingen · NCT05943067Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Chil
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07693881Anti-CD25 Monoclonal Antibody for Prevention of Acute GVHD After Haploidentical HSCT
Phase 3 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07689630Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hemat
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05011422Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05902416Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT07162038Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
Phase 2 · 4 location(s) · New York Medical College · NCT02675959CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation
Phase 2 · 1 location(s) · Hong Kong Children's Hospital · NCT06034535Haplo-HSCT for Myelofibrosis
NA · 1 location(s) · Peking University People's Hospital · NCT06674382Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
Phase 2 · 1 location(s) · University of Illinois at Chicago · NCT03121001CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transp
Phase 1 · 1 location(s) · St. Jude Children's Research Hospital · NCT07257419Haploidentical Hematopoietic Stem Cell Transplantation With Early ATG and Low Dose Post-transplant Cyclophosphamide
Phase N/A · 1 location(s) · Samsung Medical Center · NCT06041893A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05027945HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Phase 2 · 1 location(s) · Henry Ford Health System · NCT03850366Prospective Clinical Trial for Children With TCRαβ Depleted vs Traditional Haplo Identicle HSCT
NA · 1 location(s) · Sijia Gu · NCT06423131Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT
EARLY_Phase 1 · 2 location(s) · Sumithira Vasu · NCT03665675A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transpl
Phase 3 · 26 location(s) · TScan Therapeutics, Inc. · NCT07702578Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01861106Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
NA · 1 location(s) · Hong Kong Children's Hospital · NCT06075563Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
Phase 3 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06381817
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.